Emergent BioSolutions
EBS
#8541
Rank
S$0.34 B
Marketcap
S$6.65
Share price
-6.36%
Change (1 day)
-48.51%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -S$0.26 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are S$0.62 Billion. In 2025 the company made an earning of S$0.18 Billion, an increase over its 2024 earnings that were of -S$92.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.26 Billion-236.95%
2025 S$0.18 B-297.64%
2024 -S$92.85 Million-88.82%
2023 -S$0.84 Billion242.73%
2022 -S$0.25 Billion-153.8%
2021 S$0.45 B-20.43%
2020 S$0.56 B278.02%
2019 S$0.14 B27.11%
2018 S$0.11 B-27.12%
2017 S$0.16 B17.21%
2016 S$0.13 B0.45%
2015 S$0.13 B73.51%
2014 S$79.15 M41.36%
2013 S$55.99 M35.2%
2012 S$41.41 M0.4%
2011 S$41.25 M-56.46%
2010 S$94.74 M76.73%
2009 S$53.6 M32.94%
2008 S$40.32 M-5.62%
2007 S$42.72 M
2005 S$61.86 M269.89%
2004 S$16.72 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$8.99 B-3,680.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.68 B-3,554.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$9.23 B-3,776.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-S$15.12 Million-93.99%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-S$14.39 Million-94.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.43 Billion 67.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$1.58 B-728.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel